Kim P. Kamdar
CIK 1535065 · last filed 2026-07-14
Kim P. Kamdar is a corporate insider who has filed 41 SEC Form 4 insider transactions across 6 companies since 2015. The most recent filing, for SERA, was dated Jul 14, 2026. Across all open-market trades the lifetime net is +$12.0K, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $111.6K across reported positions. 11 SEC filings were submitted jointly with JAMES C BLAIR.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$111.6K
6
41
$12.0K
Filer Profile
ONE PALMER SQUARE, SUITE 515
PRINCETON, NJ 08542
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| SERA | Director | 54,999 | $2.03 | $111.6K | $0 | 6 | 2026-07-14 |
| Singular Genomics Systems, Inc. (OMIC) Delisted | Director | 132,633 | $20.01 | $2.65M | -$362.0K | 5 | 2024-05-31 |
| Evofem Biosciences, Inc. (EVFM) Delisted | Director | 10 | $0.01 | $0 | $23.0K | 8 | 2022-05-06 |
| Vyome Holdings, Inc (OBLN) Delisted | Director | 9,049 | $9.15 | $82.8K | $351.0K | 9 | 2020-09-18 |
| Evofem Biosciences, Inc. (NEOT) Delisted | Director | — | — | — | $0 | 4 | 2017-06-22 |
| SNDX | Director | — | $18.18 | — | $0 | 1 | 2016-11-02 |
Recent Filings
41 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-07-14 | SERA | Grant (A) | +25,847 | $0 | EDGAR |
| 2026-02-04 | SERA | Other (J) | −27,689 | $0 | EDGAR |
| 2025-06-06 | SERA | Grant (A) | +15,596 | $0 | EDGAR |
| 2025-02-25 | — | Disp (D) | −3,793,985 | $0 | |
| 2024-06-07 | SERA | Grant (A) | +7,117 | $0 | EDGAR |
| 2024-05-31 | Singular Genomics Systems, Inc. (OMIC) Delisted | Grant (A) | — | $0 | EDGAR |
| 2023-12-22 | — | Sell (S) | −10 | -$6 | |
| 2023-12-14 | SERA | Notice (144) | −17,796 | -$89.0K | EDGAR |
| 2023-12-14 | SERA | Notice (144) | −2,398,443 | -$11.99M | EDGAR |
| 2023-08-15 | — | Notice (144) | −200,000 | -$107.0K | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.